RB1 and neoplasm: TAPC‐4 can downregulate cyclin D1 expression and subsequently RB phosphorylation to block the cell cycle in G0/G1 phase, resulting in the inhibition of tumor cell proliferation with IC50 values of approximately 10 μm.